Federated Kaufmann Fund
Federated Kaufmann Fund specializes in the fields of mutual funds, managed accounts institutional, and separate accounts.
Business Model:
Revenue: $1.4B
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Federated Kaufmann Fund Information
Geographic Data
Address: 1001 Liberty Avenue
City: Pittsburgh
State: PA
Zip: 15222-3779
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$2B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Federated Kaufmann Fund is an investment management firm that specializes in the fields of mutual funds, managed accounts institutional, and separate accounts. IT offers equity, international, fixed income, alternative, and money market strategies.
Contact Phone:
+14122881900
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2020 | Lordstown Motors | Post-IPO Equity | 500M |
| 9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
| 10/2020 | Rezolute | Post-IPO Equity | 41M |
| 4/2021 | CeQur SA | Series C | 0 |
| 8/2021 | Laronde | Series B | 440M |
| 4/2023 | Regulus Therapeutics | Post-IPO Equity | 0 |
| 6/2021 | WM Technology | PIPE | 325M |
| 6/2021 | BarkBox | Post-IPO Equity | 0 |
| 11/2021 | Regulus Therapeutics | Private Placement | 34.6M |
| 5/2002 | Onyx Pharmaceuticals | Venture Round | 20M |
| 7/2020 | Frequency Therapeutics | Post-IPO Equity | 42.3M |
| 3/2021 | Paysafe | Post-IPO Equity | 0 |
| 10/2020 | Fisker | Post-IPO Equity | 0 |
| 10/2009 | Threshold Pharmaceuticals | Post-IPO Equity | 35M |
| 3/2021 | Century Therapeutics | Series C | 0 |
| 5/2007 | Spectrum Pharmaceuticals | Post-IPO Equity | 0 |
| 7/2021 | Hyzon Motors | Post-IPO Equity | 0 |
| 3/2021 | Graphite Bio | Series B | 150.7M |
| 2/2006 | Insulet Corporation | Series E | 0 |
| 7/2021 | AvePoint | Post-IPO Equity | 140M |
| 5/2021 | Blue Owl | Post-IPO Equity | 0 |
| 5/2021 | NeoGenomics | Post-IPO Equity | 0 |
| 2/2014 | BioDelivery Sciences | Post-IPO Equity | 60M |
| 6/2021 | Talkspace | Post-IPO Equity | 0 |
| 9/2021 | Archer | Post-IPO Equity | 0 |
| 6/2021 | Taboola | Post-IPO Equity | 0 |
| 6/2002 | Dexcom | Series C | 0 |
| 7/2020 | Molecular Partners | Post-IPO Equity | 0 |
| 1/2006 | Cytokinetics | Post-IPO Equity | 33M |
| 11/2021 | Regulus Therapeutics | Post-IPO Equity | 0 |
| 9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
| 9/2021 | Archer | Post-IPO Equity | 0 |
| 8/2021 | Laronde | Series B | 0 |
| 7/2021 | Hyzon Motors | Post-IPO Equity | 0 |
| 7/2021 | AvePoint | Post-IPO Equity | 0 |
| 6/2021 | Taboola | Post-IPO Equity | 0 |
| 6/2021 | Talkspace | Post-IPO Equity | 0 |
| 6/2021 | WM Technology | Post-IPO Equity | 0 |
| 6/2021 | BarkBox | Post-IPO Equity | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
